glp-1 tablets vs injection The FDA has approved oral Wegovy—a daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP-1s. As Midi's Chief Medical Officer, Dr. Kathleen Jordan explains: if Comparing Oral vs. Injectable Semaglutide

Medications that can enhance the activity of insulin (so-called incretin mimetics) can help to overcome insulin resistance caused by SGAs (and potentially by other psychotropic medications) and essentially lead to weight loss through enhanced fuel efficiency. Metformin, typically dosed up to 1,000 mg twice daily with meals, has increasingly become recognized as a first-line strategy to attenuate weight gain and glycemic dysregulation from SGAs via its ability to reduce insulin resistance

Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know

The Oral Small-Molecule GLP-1 Competition Orforglipron isn't the only oral small-molecule GLP-1 agonist in development

Conversely, patients with diarrhoea should maintain hydration and may benefit from temporarily reducing fibre intake whilst symptoms persist